You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 7 No. 5, Sep-Oct 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Topics
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cosmetic Surgery/ Procedures
 •Surgery
 •Laser Surgery
 •Dermatology
 •Vascular Malformations
 •Alert me on articles by topic

Description and Analysis of Treatments for Port-wine Stain Birthmarks

Kristen M. Kelly, MD; Bernard Choi, PhD; Samantha McFarlane, MD; Alison Motosue, MD; Byungjo Jung, PhD; Misbah H. Khan, MD; Julio C. Ramirez-San-Juan, PhD; J. Stuart Nelson, MD, PhD

Arch Facial Plast Surg. 2005;7:287-294.

Port-wine stain (PWS) birthmarks are congenital, low-flow vascular malformations of the skin. Lasers are the modality of choice for the treatment of PWS birthmarks, and for most patients the pulsed-dye laser in conjunction with epidermal cooling offers the greatest efficacy and safety. Other light devices, including the 532-nm frequency-doubled Nd:YAG laser, intense pulsed light, 1064-nm Nd:YAG laser, and combined 1064/532-nm system, may be useful during a treatment course for resistant PWS. Laser treatment results in blanching of most lesions, although complete resolution may not occur and some resistant PWS birthmarks respond minimally, if at all. Factors limiting laser treatment include variable vascular geometry, inadequate damage of some vessels, and lesional posttreatment recurrence as a result of neovascularization. Alternative or adjunct treatment options that address these limitations should be explored, including noninvasive real-time imaging to optimize the selection of treatment settings, photodynamic therapy, and perioperative use of antiangiogenic compounds.


Author Affiliations: Beckman Laser Institute, Irvine (Drs Kelly, Choi, Jung, Khan, Ramirez-San-Juan, and Nelson), and Departments of Dermatology (Drs Kelly, McFarlane, and Nelson), Pediatrics (Dr Motosue), and Biomedical Engineering (Dr Nelson), University of California–Irvine; Department of Biomedical Engineering, Yonsei University, Seoul, South Korea (Dr Jung); and Department of Optics, Instituto Nacional de Astrofisica, Optica y Electronica, Puebla, Mexico (Dr Ramirez-San-Juan).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.